Advertisement

Hyperhidrosis pp 253-260 | Cite as

Quality-of-Life Evaluation During Treatment of Hyperhidrosis

  • Hugo Veiga Sampaio da Fonseca
  • José Ribas M. de Campos
Chapter

Abstract

The assessment of quality of life (QoL) is the best way to evaluate the short- and long-term response of the various therapies for hyperhidrosis as a disease that interferes directly with human behavior. The use of QoL questionnaires is the most practical way of performing this evaluation. Oxybutynin is a safe medication with proven effects, making it a good alternative for patients of all ages and for those who do not want surgery. It has a significant impact on QoL and sustained effect while continuing to be taken. Sympathectomy is the definitive surgical procedure that offers the best long-term results, with high rates of satisfaction and impact on QoL, despite being irreversible and always accompanied by some degree of compensatory hyperhidrosis. Although a minority of patients deny their occurrence, less than 2% of patients regret sympathectomy. The best way to prevent surgical regret is through robust patient selection and by avoiding higher resections in the sympathetic chain.

Keywords

Quality of life Hyperhidrosis Oxybutynin Sympathectomy Compensatory hyperhidrosis 

Suggested Reading

  1. Cerfolio RJ, De Campos JRM, Bryant AS, Connery CP, Miller DL, DeCamp MM, et al. The Society of Thoracic Surgeons expert consensus for the surgical treatment of hyperhidrosis. Ann Thorac Surg. 2011;91(5):1642–8.CrossRefPubMedGoogle Scholar
  2. Milanez De Campos JR, Kauffman P, De Campos Werebe E, Andrade Filho LO, Kusniek S, Wolosker N, et al. Quality of life, before and after thoracic sympathectomy: report on 378 operated patients. Ann Thorac Surg. 2003;76(3):886–91.CrossRefGoogle Scholar
  3. Milanez De Campos JR, da Fonseca HVS, Wolosker N. Quality of life changes following surgery for hyperhidrosis. Thorac Surg Clin. 2016;26:435–43.CrossRefGoogle Scholar
  4. Pompili C, Novoa N, Balduyck B. Clinical evaluation of quality of life: a survey among members of European Society of Thoracic Surgeons (ESTS). Interact Cardiovasc Thorac Surg. 2015;21(4):415–9.CrossRefPubMedGoogle Scholar
  5. Wolosker N, de Campos JRM, Kauffman P, Puech-Leão P. A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis. J Vasc Surg. 2012;55(6):1696–700.CrossRefPubMedGoogle Scholar
  6. Wolosker N, Schvartsman C, Krutman M, Campbell TPDA, Kauffman P, De Campos JRM, et al. Efficacy and quality of life outcomes of oxybutynin for treating palmar hyperhidrosis in children younger than 14 years old. Pediatr Dermatol. 2014;31(1):48–53.CrossRefPubMedGoogle Scholar
  7. Wolosker N, Teivelis MP, Krutman M, de Paula RP, Schvartsman C, Kauffman P, et al. Long-term efficacy of oxybutynin for palmar and plantar hyperhidrosis in children younger than 14 years. Pediatr Dermatol. 2015;32(5):663–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Hugo Veiga Sampaio da Fonseca
    • 1
  • José Ribas M. de Campos
    • 2
  1. 1.Royal Thoracic Surgery Clinic – Royal Portuguese Hospital of Beneficense in PernambucoRecifeBrazil
  2. 2.Thoracic SurgeryUniversity of São Paulo and Hospital Israelita Albert EinsteinSão PauloBrazil

Personalised recommendations